Prioritisation of Acute Appendicitis Using Appendistat Score
APEX
Prioritization of Patients With Suspected Acute Appendicitis Using the Appendistat Score (APS)
1 other identifier
observational
592
1 country
2
Brief Summary
Introduction Although non-operative management of acute appendicitis may be appropriate in selected cases, surgery remains the gold standard treatment. Prioritization of patients at risk of developing complicated appendicitis is essential for improving outcomes. The aim of this study was to assess the predictive value and clinical utility of the Appendistat (APS) scoring system as a triaging tool to prioritize patients with a high risk of developing complicated appendicitis. Methods This was a chart review, cross-sectional observational diagnostic study, with a single-gate retrospective design, including 592 patients who underwent appendicectomy. Based on final histological diagnosis, patients were categorized as normal, acute uncomplicated appendicitis (AUA), or acute complicated appendicitis (ACA). The predictive value matrix of the APS score for identifying patients with a histological diagnosis of complicated appendicitis was calculated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2024
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 6, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 2, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 2, 2025
CompletedFirst Submitted
Initial submission to the registry
September 9, 2025
CompletedFirst Posted
Study publicly available on registry
September 29, 2025
CompletedSeptember 29, 2025
September 1, 2025
11 months
September 9, 2025
September 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Area under the receiver operating characteristic (ROC) curve (AUC) of the Appendistat Score (APS) for predicting histologically confirmed complicated appendicitis
Diagnostic accuracy of APS assessed by calculating the AUC of the ROC curve for discriminating complicated appendicitis from
At time of hospital admission (within 24 hours of presentation)
Secondary Outcomes (2)
Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the Appendistat Score (APS) for detecting complicated appendicitis
At time of hospital admission (within 24 hours of presentation)
Mean Appendistat Score (APS) values in patients with histologically confirmed uncomplicated vs. complicated appendicitis
At time of hospital admission (within 24 hours of presentation)
Study Arms (1)
Right iliac fossa pain
Post operative classification into: acute uncomplicated appendicitis; acute complicated appendicitis; and normal appendix
Eligibility Criteria
Patients presenting to the surgical assessment unit with acute right iliac fossa pain
You may qualify if:
- Patients aged 16-years and above, with a conclusive histological report were included.
You may not qualify if:
- hysterectomy, and those without a conclusive pathology report were excluded
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University College London
London, OX3 8PF, United Kingdom
Oxford University Hospitals NHS Trust
Oxford, United Kingdom
Related Publications (1)
Lerea KM, Livingston JN. The different receptor species of liver have similar complex insulin binding properties. Biochem Biophys Res Commun. 1983 Aug 12;114(3):1042-7. doi: 10.1016/0006-291x(83)90667-8.
PMID: 6351858BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 5 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 9, 2025
First Posted
September 29, 2025
Study Start
January 6, 2024
Primary Completion
December 2, 2024
Study Completion
August 2, 2025
Last Updated
September 29, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share